Home > Insider Trading > Filing (0001209784-17-000019)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1116463	Orasure Technologies Inc	OSUR	Surgical & Medical Instruments & Apparatus (3841)	364370966

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1209784	L Mark Kuna	220 East First Street Bethlehem PA 18015	Svp & Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2017-02-09	15,000	$10.00	63,491	No	4	S	Direct
Common Stock	Acquisiton	2017-02-10	33,700	$6.63	97,191	No	4	M	Direct
Common Stock	Acquisiton	2017-02-10	30,571	$5.71	127,762	No	4	M	Direct
Common Stock	Disposition	2017-02-10	64,271	$10.75	63,491	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nonqualified stock option	Disposition	2017-02-10	33,700	$0.00	33,700	$6.63
Common Stock	Nonqualified stock option	Disposition	2017-02-10	30,571	$0.00	30,571	$5.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-02-01	No	4	M	Direct
10,190		2024-02-03	No	4	M	Direct

Footnotes

Sale pursuant to a predetermined sales plan, entered into on August 31, 2016, under Rule 10b5-1 of the Securities and Exchange Act of 1934.
Nonqualified stock options granted on February 1, 2011 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.
Nonqualified stock options granted on February 3, 2014 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.